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INTRODUCTION 
Enterocutaneous fistulas develop most commonly as a postoperative 
complication of bowel surgeries, though in 15 to 20% of cases, they occur 
spontaneously.  Spontaneous fistula may arise in patients with inflammatory 
bowel disease, radiation enteritis, diverticular disease, perforated duodenal 
ulcer, pancreatic and gynecological malignancies. Crohns disease is the most 
common primary bowel disease leading to enterocutaneous fistulas.  
Surgical treatment may be difficult because additional fistulas may develop 
in these patients postoperatively. 
The vast majority of fistulas occur in the postoperative setting.  They 
are frequent after emergency surgeries, when the patient preparation is poor 
or in the chronically debilitated and malnourished patients. 
The common causes include disruption of anastomotic suture line, 
unintentional enterotomy, or inadvertent bowel injury during closure. 
They remain one of the important challenges to the surgeon because 
of their anatomical abnormalities, metabolic derangement and extensive 
sepsis associated with them. 
  6
HISTORICAL ASPECTS 
History dates back to 1043 BC when Samuel has written about Eglon, 
who sustained post traumatic fistula in The Old Testament Book of Judges. 
“And Enad put forth his hand, and took the dagger and thrust it into his 
belly… And the dirt came out.” 
FISTULA is a word coined from a similar Latin word for pipe.  It also 
has a French origin from the word ‘Festre’ which led to the English word 
‘Fistle’ and ‘FISTULA’. 
Until 18th century, management of fistula was by an attempt at 
surgical closure as advocated by Celsus which resulted in most number of 
failures in the management of fistula.  During the 18th Century, a Paradigm 
shift in the management of fistula advocated by John Hunter, favored 
conservative therapy of wait and watch policy for spontaneous closure. 
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AIMS OF THE STUDY 
The aims of this study are to analyze all cases of enterocutaneous 
fistulas treated at Government Royapettah Hospital, Kilpauk Medical 
College, from June 2005 to September 2007 and 
1. To identify the factors influencing spontaneous closure and mortality 
in patients with ECF. 
2. To determine serum albumin levels by which we can accurately 
predict the outcome of patient with ECF. 
3. To assess the importance of parenteral nutrition in the management of 
fistula. 
4. To search for effective preventive measures on this enervating and 
demoralizing phenomenon. 
Various literatures have been reviewed and are discussed in detail. 
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REVIEW OF LITERATURE 
A fistula is an abnormal communication between two epithelialised 
surfaces.  An internal fistula connects two hollow viscera or potential 
spaces with each other.  External fistulas connect a hollow viscus to the 
body surface.  Simple fistulas have a single direct tract, whereas 
complicated ones have multiple tracts or an associated abscess.  Lateral 
fistulas have a leak from the side of a hollow viscus and end fistulas have 
a leak from the whole diameter of the section of the involved bowel. 
Historically, the earliest record of an ECF appeared in the Old 
Testament book of judges (1043-1004 BC.), it is the account of Eglon, 
who sustained an acute posttraumatic ECF.  Thilesus in 1670 reported 
biliary fistula due to spontaneous perforation of gallstones through the 
abdominal wall.  Teale in 1841 reported a fistula in a strangulated 
inguinal hernia.  Alexis St. Martin developed a gastric fistula following a 
gunshot wound and was used by Beaumont in 1833, as a means of 
researching gastric physiology.  While John Hunter advocated a 
conservative approach to fistulas in the 18th century, Celsus described the 
first attempt at surgical repair of an ECF. 
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CLASSIFICATION 
The most commonly used schemes for classification are anatomic, 
physiologic and etiologic which are not exclusive of one another. 
Scheme Classification Significance 
Anatomic Internal 
External 
Organ Involved 
Suggests etiology, 
Prognosticates 
spontaneous closure, 
helps plan operative time 
and approach. 
Physiologic Output (ml/Day) 
Low <200 ml 
Moderate 200 to 500 ml 
High> 500 ml 
Prognosticates mortality 
but not spontaneous 
closure, assist in 
anticipating and treating 
metabolic deficits. 
Etiologic Underlying disease 
process 
Prognosticates 
spontaneous closure and 
mortality 
 
Sitges - Sera et al proposed an alternative classification of 
postoperative ECF which integrates the role of nutrition, surgery and 
prognosis of a given patient, which can be used a guideline to treatment. 
Group1:  Oesophageal, gastric, small bowel and ileocolic fistulas 
a:  Low Output (<1000 ml/48 hr) 
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b:  High output (>1000 ml /48 hr) 
Group 2  :  Fistulas through a large abdominal wall defect 
Group 3  :  Appendiceal and colo-colic fistulas 
ETIOLOGY 
ECF are usually acquired but are occasionally congenital, e.g. a patent 
vitello intestinal duct with a fistula.  Acquired fistulas may be spontaneous 
or post operative.  Spontaneous fistulas occur when a disease extends out of 
the organ of origin to invade surrounding tissues.  Postoperative fistulas are 
a consequence of loss of integrity of the intestine. 
Leakage of intestinal juices causes localized infection, abscess 
formation, and burrowing of septic focus into body surface.  A wound 
abscess appears 5 to 6 days after surgery and is drained.  Within the next 24 
hrs, enteric contents appear on the wound surface.  Both local and systemic 
factors like infection, inflammation, distal obstruction, malnutrition, 
immunosupression etc. influence fistula formation. 
In the early 1900s, most fistulas were spontaneous.  Lewis et al 
reviewed 109 cases of ECF from John Hopkins Hospital, Baltimore from 
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1891-1931 and showed that almost 60% were associated with infection.  
Appendicectomy was responsible for less than 20% of all ECF.  After 1960, 
the majority of ECF are postoperative. 
Spontaneous causes include radiation, inflammatory bowel diseases, 
malignancies, tuberculosis etc.  Postoperative enterocutaneous fistula usually 
follows operations for cancer, IBD and adhesions from previous surgery.  
Other causes include operations for peptic ulcer, pancreatitis, trauma etc.  
Fistulas more commonly occur following emergency surgery.  Systemic 
abnormalities that impair wound healing like sepsis, steroids, diabetes, 
chemotherapy also influence the formation of postoperative fistulas. 
More than half of postoperative enterocutaneous fistulas are due to 
unrecognized bowel injuries during adhesiolysis or abdominal closure.  The 
remaining is due to disrupted anastomoses. 
This may be due to inadequate blood flow as a result of 
devascularization or systemic hypotension, tension on the suture lines, 
perianastomotic abscesses, anastomosis on diseased bowel, inadequate 
bowel preparation, poor drain placement and malnutrition. 
  12
Gastric fistulas are postoperative in 80 to 90% of the cases.  The 
average time for closure is 40 days and overall mortality is 20%.  Duodenal 
fistulas are postoperative in 50-80% of cases, overall mortality is 30% and 
spontaneous closure occurs in about 20 days. 
Small intestinal fistulas are the commonest type of ECF encountered, 
of which 70 to 90% are postoperative.  Other causes include Crohns disease, 
cancer, etc., mortality is 20 to 40%.  Chronic fistulas occur as a result of 
IBD, diverticulitis, cancer and radiotherapy or secondarily from surgical 
treatment of these diseases.  Most of these heal spontaneously in 30 to 40 
days, mortality is 10 to 20%. 
As the majority of ECF are due to technical failures, well 
vascularised, tension-free anastomoses performed in healthy bowel in 
nutritionally replete patients, will decrease postoperative complications in 
general and fistula formation in particular. 
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COMPLICATIONS 
The major morbidity and mortality from ECF are related to 3 
complications –fluid and electrolyte imbalance, malnutrition and sepsis.  The 
initial metabolic consequence of an ECF, especially the high output one is 
loss of water and electrolytes and the severity increases as the fistula gets 
closer to the ligament to treitz. 
The daily volume of secretions in to the gut amounts to 20% of total 
body water.  Also each day, 1/3rd of the total exchangeable sodium and 
chloride in the body is secreted into the gut and reabsorbed and 20% of the 
body’s extracellular potassium is secreted into the gut per day. 
Fluid and electrolyte imbalances accounted for 78% of deaths in ECF 
in the 1960’s but improvements in fluid management has decreased the 
mortality by more than 50%.  Dehydration, hyponatremia, and metabolic 
acidosis are common problems. 
Malnutrition is a major problem in ECF.  Scoeters et al noticed a 74% 
incidence of malnutrition in his series of patients with ECF.  Coutsofides 
noted a 66% incidence of malnutrition and found that, mortality was 32% in 
the malnourished and only 4% in well-nourished patients.  Malnutrition is 
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more severe in high output fistulas due to hypercatabolism, lack of adequate 
nutrient intake and loss of protein rich secretions from the fistula. 
Sepsis is the most common complication and cause of death in ECF. 
Unless sepsis is controlled, it is impossible to correct malnutrition. 
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MANAGEMENT 
There are five phases in the management of an ECF 
1. Stabilization  : Within 48 hours 
2. Investigations : after 7-10 days 
3. Decision making : 10 days to 4-6 wks 
4. Definitive Therapy: after 4-6 wks 
5. Healing  : 5 to 10 days of closure 
The aim of stabilization is to control the three major complications of 
a fistula and consists of rehydration, electrolyte repletion, correction of 
anemia, drainage of sepsis, restoration of oncotic pressure, nutritional 
support, control of fistula drainage and institution of skin care. 
A period of stabilization allows the peritonitis to subside, 
inflammation to resolve and improvement of the nutritional status.  This 
improves the outcome of subsequent surgery, if spontaneous closure has not 
already occurred.  The priority is to restore circulatory volume and correct 
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electrolyte imbalances.  Initially a peripheral venous line is used.  Once the 
patient is stabilized, a central venous catheter is preferable to deliver fluids. 
The deficit caused by a fistula is directly proportional to the volume 
and composition of the effluent and the rate at which it is lost.  The 
composition of the fistula output and of the fluid that correlates with the 
anatomic location of the fistula may not be the same.  Hence the fistula 
effluent must be collected accurately and its volume and composition 
measured.  Resuscitation is best carried out with a plasma expander followed 
by crystalloids.  Blood is used only if there is extensive blood loss.  CVP 
monitoring is mandatory for correction of fluid balance. 
The daily requirements are 35 to 45 mI/kg water, 75 mmol Sodium 
and 70 mmol potassium.  To this, daily fistula losses must be added.  Fluid 
and electrolyte requirements must be reviewed everyday initially.  Good 
guides to the adequacy of replacement are the urine sodium level and urine: 
plasma osmolality ratio, which can give an early warning of fluid overload. 
Routine use of nasogastric tube has been advocated by Tarzani et al, 
but several series have failed to demonstrate improved outcome with use of 
NG tube in distal or low output fistulas. 
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Antisecretory drugs like ranitidine, omeprazole, or somatostatin 
(Octreotide) can reduce fistula output.  When compared to TPN alone, 
Octreotide does not improve overall closure rate but in a collected series, the 
closure time decreased significantly from 50 days with TPN alone to 5 to 10 
days when Octreotide was also used, Boike et al reported on 27 patients with 
ECF, treated with Octreotide and showed decreased fistula output by 55% in 
first 24 hours.  A 77% spontaneous closure rate was achieved with TPN and 
Octreotide after an average of 5.8 ± 2.7 days, compared with 4 to 6 weeks of 
TPN alone. 
Nutritional support has become the mainstay in the management of 
ECF improving the outcome.  To optimize nutrient metabolism, circulation 
and tissue oxygenations must be adequate.  The goal of nutritional therapy is 
nitrogen equilibrium with maintenance or restoration of structural and 
functional protein synthesis. 
Nutritional support is started soon after resuscitation.  Oral intake is 
stopped while determining the optimal route for nutritional support.  Hull 
and Barnes first observed that total parenteral nutrition actually reduced 
fistula output.  This was confirmed in clinical studies by Chapman, Mac 
fayden and Kaminiski.  Elemental diet was also shown to reduce fistula 
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output.  Wolfe et al, showed in experimentally created fistulas in dogs, that 
fistula output and nutritional losses reduced by 81 and 93 % by using enteral 
and parenteral nutrition respectively. 
Nutritional therapy is primarily supportive but may have a therapeutic 
role by modifying GI secretion.  TPN replaces fluid and electrolytes, 
provides adequate nutrition and alleviates the catabolic state and reduces 
fistula output. 
Parenteral nutrition is the initial method of support in ECF.  The high 
osmolarity of TPN solution precludes the use of peripheral veins for 
delivery.  So access to central veins like the subclavian or internal jugular is 
essential where the large blood flow immediately dilutes the nutrients. 
For anabolism to occur, usable source of nitrogen and calories must be 
provided.  Thus patients on TPN must have infused synthetic aminoacids 
containing an equivalent of nitrogen lost plus an additional 2-3 g with a 
suitable energy source. Energy requirement takes into account resting energy 
expenditure, stress factor and activity factor. 
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BME is calculated by Harris – Benedict equation, 
For men: BME (K Cal /d) = 66.4730 + 13.7516 (W) + 5.0033 (H) – 
6.7550 (A)  
For women: BME (K Cal / d) = 655.095 + 9.563 (W) + 1.8596 (H) – 
4.6756 (A)  
Parenteral glucose should constitute the major caloric source in TPN 
and the rest should come from fat, as only glucose significantly suppresses 
gluconeogenesis. Fat can achieve protein sparing and supply essential fatty 
acids. 
Additional requirements include essential fatty acids, vitamins, trace 
elements and hematinics.  TPN has been reported to lower the mortality rates 
to as low as 5.3 %, though this has not been possible in other series.  
However TPN increases the rate of spontaneous closure. 
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COMPLICATIONS ASSOCIATED WITH USE OF TPN 
Mechanical: 
 Catheter tip malposition 
 Arterial laceration  
 Hydropneumothorax 
 Subclavian or Superior Vena Cava thrombosis  
 Thrombophlebitis 
 Catheter embolism  
Septic: 
 Catheter related sepsis  
Metabolic: 
 Acute:  
  Hyperglycemia / Hypoglycemia 
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  Electrolyte abnormalities 
  Fluid overload 
  Hyperlipidemia 
 Chronic: 
  Metabolic Bone disease 
  Alteration in bile composition  
  Deterioration of liver function 
The introduction of 3 litre bags made of ethyl vinyl acetate has made 
the admixture of a fat emulsion to dextrose and amino acids possible.  The 
advantages are: 
1. Cost saving during preparation and delivery 
2. More uniform administration of a balanced solution 
3. Less manipulation and contamination 
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4. Obviation of care for peripheral catheter used solely for the 
administration of lipids, in order to avoid inserting a central venous 
catheter 
5. Decreased lipid toxicity 
6. Ease of delivery and storage for patients on home TPN. 
7. The option of delivering nutritional support peripherally and 
8. Reduced long term hepatic accumulation of triglycerides. 
Enteral nutrition may be used after an initial period of TPN in 
oesophageal, ileal and colonic fistulas. Enteral nutrition especially glutamine 
supports gastro intestinal mucosal growth and function especially when the 
gut mucosal barrier is compromised. Short chain fatty acids are a fuel source 
for enterocytes.  Levy et al reported spontaneous closure in 88% and 
mortality in 19% of patients treated with elemental diet.  The efficacy of 
enteral nutrition has been reproduced in many studies.  Meticulous catheter 
maintenance protocol and regular monitoring by clinical and lab tests are 
needed to prevent complications. 
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CATHETER MAINTENANCE PROTOCOL 
Cut down site : Dry sterile dressing until wound heals, then no dressing 
Catheter exit site : Daily skin cleaning with alcohol and 3% H2O2.  Sparingly  
   apply antiseptic ointment on dry sterile dressing 
Catheter  : Heparin flush following blood sampling or daily use 
  No Millipore filter 
Monitoring the patient on TPN requires the following clinical data to be 
checked daily. 
Patient sense of well being: 
Symptoms suggesting fluid overload, high or low blood glucose 
electrolytes imbalance etc. 
Patient’s strength as judged by graded activity: 
Getting out of bed, walking stair climbing. 
Vital Signs  : Temperature, blood pressure, pulse rate, respiratory rate 
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Fluid Balance : Weight, fluid input (intravenous ± essential) versus 
   fluid output (Urine, stool, gastric suction etc.) 
Delivery equipment for TPN : Composition of nutrition solution, tubing,  
  pump, filter, catheter dressing (Skin   
  checked for local infection at time of   
  dressing change.) 
LABORATORY DATA:  Urine quantitative glucose:  Daily until patient  
stable then twice weekly. 
BLOOD: 
Na, K, Cl, HCO3, Glucose 
Blood Urea Nitrogen 
Albumin, Creatinine 
Liver Function Studies 
Ca², PO4, Mg² 
Cholesterol, Triglyceride 
Prothrombin time, baseline, then biweekly 
Micronutrient tests as indicated. 
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COMPLICATIONS OF ENTERAL NUTRITION 
Mechanical complication:  The mechanical complication of enteral 
feeding fall into two broad categories – low – frequency, high morbidity 
complications and higher frequency, low – morbidity complications. 
Low frequency high morbidity complications include injury along the 
nasogastric tube insertion site, arterial erosion, perforation of the GI tract 
and aspiration pneumonitis.  High frequency low morbidity mechanical 
complications consist mostly of dislodgement of feeding tubes with both 
weighted and unweighted tips as well as the red rubber tubes. 
Metabolic complications:  The metabolic complications and their 
frequency in enteral nutrition include fluid overload 31%, electrolyte 
imbalance 30%, hyperglycemia 30% and uremia and dehydration 15%, 
symptoms of abdominal bloating.  Cramps and diarrhea are related to high 
rates of feeding and to the high caloric density of the formula (i.e., high fat 
content), although paralytic ileus and the side effects of para-
sympathomimetic drugs must be excluded. 
Among the pathogenesis of tube – feeding diarrhea is the use of 
contaminated tube feedings, lactose intolerance, high osmotic loads, 
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inappropriate release of gastrointestinal polypeptide hormones, concomitant 
antibiotic therapy, use of laxatives and hypoalbuminemia. 
Infectious complications: Infectious complications are one of the most 
commonly reported side effects of enteral tube feeding.  Bacterial 
contamination of the enteral nutrient solution has been reported to occur in 
30% to 90% when using open enteral feeding system.  This leads to diarrhea.  
Other factors include the use of enteral powders requiring mixing of either 
sterile or tap water to dilute the formula. A consequence of the diarrhea is its 
associated increased morbidity related to fluid and electrolyte losses. To 
minimize contamination of enteral nutrient solutions, it is recommended to 
use a closed delivery system, a prepacked sterile enteral formula, and a 
sterile administration set. 
Indications for stopping nutritional support include life threatening 
complications, terminal illness and when fistula is close to healing.  
However, Meguid et al recommended waiting after fistula closure, until the 
patient eats 60% of his requirements before withdrawing nutrition supports. 
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Access to GIT may be oral, nasogastric or nasoenteral through a 
gastrostomy or jejunostomy. The various enteral feeds include disease-
specific, elemental, whole protein, modular or supplemental feeds. 
Nutritional requirements in ECF: 
 Fluids: 30 to 40 ml/kg/day 
 Sodium: 70 to 100 mEq/day 
 Potassium: 70 to 100 mEq/day 
 Calories: 35 to 40 kcal/kg/day 
 Protein: 1 to 1.5 g/kg/day 
 Nitrogen: 0.17 to 0.34 g/kg/day 
 N2 : NPC: 1:150 to 300 
 CHO: Fat: 70:30 
Sepsis in ECF may be directly related to the fistula, like wound 
infection, or may be due to indirect causes like UTI, catheter sepsis etc. 
Eradication of infection may help heal a fistula spontaneously without 
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surgical intervention. The first step in managing sepsis is to provide 
adequate drainage. 
This controls the fistula and protects the skin. Any local wound 
infection must be treated with incision and drainage or debridement if 
necessary. 
If signs of sepsis are present, an intra abdominal abscess must be ruled 
out.  If absent, other sources must be ruled out. Antibiotics must be used 
only after drainage of any intra abdominal sepsis. Abscess may be drained 
by percutaneous, transperitoneal or extra peritoneal routes. Percutaneous 
abscess drainage is the preferred method. Closure rates of 50 to 84% have 
been reported in low output fistulas by this method.  
Reoperation for sepsis in ECF has a high mortality and must be 
considered only after other options are exhausted, but a patient must never 
be allowed to go downhill progressively without an operative search for 
occult sepsis. 
The decision to proceed with operation in this setting should be 
undertaken only after all options have been thoroughly considered and risk 
versus benefit assessed. In most cases of patients with GI fistulas, when the 
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indication is sepsis or a sepsis related complication, the procedure is 
generally performed on an emergency basis. 
In general it is best to identify and localize the intra-peritoneal 
location of the septic focus prior to re-exploration.  The operative incision 
and approach should be governed by the nature and location of the infection 
prior to operation and the surgeon’s experience. The act of re-entering the 
abdomen in a patient with a fistula may be quite challenging.  Some 
surgeons advocate a new and separate incision through virgin territory, 
others prefer to go through the previous incision and attempt to isolate the 
fistula as a pedicle and carefully separate the incision from the viscera. 
 It is essential to expose the entire GI tract to be sure that there 
are no points of obstruction distal to the fistulous opening. Abscess cavities 
are drained, sampled for culture and irrigated, sialastic sump drains are left 
to drain any suspicious areas, particularly those with sticky fibrinous 
exudates.  The drain should be brought through the abdominal wall with 
counter incision low in the flank, to offer the most dependent drainage from 
a supine position. 
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By the end of a laparotomy for drainage of abscesses, the intestine is 
often oedematous and filled with fluid, creating a much larger volume than 
that found upon entering the peritoneal cavity. 
This creates increased tension on the abdominal wall when trying to 
re-approximate the edges of fascia.  Under these circumstances there are a 
few options, one is to “Milk” the intestinal contents back into the stomach 
and aspirate them via the transgastric jejunal tube, gastrostomy or 
jejunostomy. Another option is to place a long tube such as a Baker, Miller-
Abbott or their equivalent and again aspirate the luminal contents as much as 
possible. 
Definitive surgery to close fistula must be avoided.  However 
proximal diverting stomas may be considered. The abdomen may be left 
open and packed temporarily (Laparostomy), this helps in repeated 
inspection and abscess drainage.  
Skin care aims to maintain skin integrity and contain due effluent and 
improve the patient’s morale.  Various methods include use of absorbents, 
charcoal, transparent dressings, skin barriers, pouches and suction catheters.  
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A closed system with suction or sump drain and lactic acid perfusion 
technique has also been used for skin care. 
The factors that determine the choice of skin protection include origin 
of fistula, nature and volume of effluent, condition of skin, location, size and 
number of fistula openings. 
High output fistulas need a pouch system and low output may be 
contained with dressing and skin barriers.  Thick effluents are contained 
with a drainable type pouch and liquid effluents with a urostomy type pouch.  
Skin barriers are used when effluent contains proteolytic enzymes or 
is extremely acidic/ alkaline.  Pouches may be ostomy pouches or wound 
drainage and wide mouthed collectors.  Skin barriers may be in the form of 
solid wafers, powder, paste, spray, ointments and creams.  Fistula with large 
open wounds may be drained by saddle bagging and bridging methods.   
Radiological investigations provide information regarding the origin, 
complexities and size of fistula, condition of adjacent bowel, continuity of 
bowel, presence of distal obstruction etc. 
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Contrast studies must be initially done with iodinated water soluble 
media.  Thin barium may be used only in case a negative examination.  
Fistulography is the most reliable way of demonstrating communication with 
underlying viscera. Ultrasound, CT Scan, hydrogen peroxide enhanced 
ultrasound fistulography are other investigations that are useful in evaluation 
of EC fistulas. 
DECISION MAKING AND DEFINITIVE THERAPY 
The main goal of therapy in ECF is to reestablish intestinal continuity 
and close the fistula.  This is most favourably achieved by spontaneous 
closure.  The use of TPN has improved the rates of spontaneous closure.  
Still operative intervention is necessary in many patients to close the fistula, 
especially in ileal fistulas which close spontaneously in only 40 % of 
patients, due to small diameter, vigorous motility and relative obstruction of 
ileocaecal valve. 
Emergency is indicated only in cases of sepsis or haemorrhage.  
Otherwise, conservative therapy is the treatment of choice in the initial 
period.  The cases considered for late elective surgery are those in which the 
fistula has not healed after 4 to 6 weeks of appropriate conservative 
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management and those where local conditions preclude spontaneous closure.  
Reoperative surgery and conservative management are not opposing forms 
of therapy, rather they are complementary. 
There are two categories of operation.  The first include those 
designed to improve general condition (e.g. drainage of abscess), correct 
malnutrition (feeding enterostomies) or control output from a difficult fistula 
(proximal diversion). 
In the second category are definitive operations to remove the fistula 
and diseased bowel.  In a well nourished patient without sepsis, resection of 
fistula and end to end anastomosis is preferred.  In a malnourished septic 
patient, proximal diversion or resection with exteriorization is done.  
Intestinal bypass is not recommended. 
Conservative treatment should be continued if the patient is improving 
as demonstrated by decreasing output, rising plasma albumin level and body 
weight and return of defecation.  Spontaneous closure is most likely to take 
place within 4 to 6 weeks of sepsis and is unlikely to happen later. Reher et 
al observed that 90% of patients who closed their fistulas did so within 1 
month after sepsis was controlled. Less than 10% closed in 2 months and 
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none after 3 months.  Fazio showed that surgical mortality and success rate 
when surgery was done before and after 6 weeks was 21 and 70% and 12 
and 84% respectively. Thus elective surgery is best undertaken atleast 4 to 6 
weeks after resolution of intra abdominal sepsis, which is usually 60 to 75 
days after initial surgery. 
Sitages-Serra et al suggested that group 1a and 3 fistulas can be 
treated conservatively. Group 1a cases are started on TPN immediately, with 
surgery reserved for those cases that do not close or if sepsis is controlled.  
Group 2 fistulas demand early surgery with post operative TPN. 
Once the decision for surgery is made, careful preparation should 
begin. The abdominal wall should be reevaluated, loculations drained and 
cellulitis aggressively treated. If meticulous skin care and control of fistula 
drainage has been achieved, the operation can be carried out through a 
healthy abdominal wall, enhancing the chance of secure abdominal closure. 
Particular attention should be paid to electrolyte and volume status 
preoperatively. Fistula drainage should be cultured and intraluminal 
antibiotics as well as targeted intravenous antibiotics should be 
administered.  If the patient has been receiving enteral nutrition therapy, 
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discontinuation one to two days preoperatively may decrease abdominal 
distension and aid in attaining a secure abdominal closure. 
The abdomen and operative site should be washed with antibacterial 
solutions for several days prior to operation. Bowel preparation, both 
mechanical and antibiotic preparation should be carried out.  Systemic 
antibiotics should always be used, as these are by definition at least clean 
contaminated cases.  Sufficient time should be allowed for this operation.  
Extensive dissection is usually necessary, with meticulous technique and 
absolute hemostasis for the prevention of further fistulization. 
The operative approach is preferably though a new incision so that the 
major operative field is relatively clean. 
If this is not possible, the old incision is used but extended for easier 
access to the abdomen.  In addition, if sepsis still exists in the abdominal 
wall, the incision should be made remote from this area.  Abscess cavity, if 
present should be drained through separate stab wounds distant from the 
primary incision.  The operative incision should be planned so that if end-to-
end anastomosis will be necessary which usually is the case, it can be carried 
out well away from the area of maximal contamination. 
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Dissection should proceed from the ligament of Treitz to the rectum 
with adhesions freed.  The best rates of closure and the lowest incidence of 
complications are obtained by definitive resection and end-to-end 
anastomosis.  The anastomosis should be carried out in a clean field away 
from any previous abscess cavity.  The omentum should be placed in its 
anatomic position with a portion covering the anastomosis. 
The importance of a secure abdominal wall closure cannot be 
overstated.  This may be difficult in patients in whom the abdominal wall 
has been partially destroyed by sepsis.  If closure is complicated, a Plastic 
Surgery Team should be employed to assist in this portion of the operation.  
In general, prosthetic reconstruction can lead to recurrent fistulas or become 
infected when used in these contaminated cases.  Musculocutaneous flaps 
should be used if adequate fascia is not available for a tension free closure. 
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FACTORS INFLUENCING THE OUTCOME OF ECF 
A review of literature has revealed eight important factors that 
influence outcome in ECF.  These are: 
1. Local fistula characteristics: 
Lower rates of spontaneous closure and higher mortality have been 
associated with distal obstruction, epithelialisation of the tract, short tracts 
less than 2 cm, complete disruption, diseased adjacent bowel, multiple 
fistulas, abdominal wall defects etc. 
2. Organ of origin: 
Spontaneous closure is more frequent and mortality is lower in 
biliopancreatic than duodeno-jejunoileal fistulas. 
3. Sepsis: 
Presence of sepsis decreases the rate of spontaneous closure and 
increases mortality.  Reber reported spontaneous closure in 90% of patients 
where sepsis was controlled and in only 6% when sepsis was not controlled, 
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with 85% mortality in the latter group.  Levy et al reported mortality rates of 
55 and 20% respectively in the presence and absence of sepsis. 
4. Etiology: 
Postoperative fistulas have a higher mortality but are more likely to 
close spontaneously.  Presence of cancer significantly increases mortality 
rates.  Fistulas associated with IBD, cancer or radiations have lower rates of 
spontaneous closure. 
5. Age: 
Age of the patient influences mortality, but not spontaneous closure.  
Reber reported mortality rates of 22% and 48% in patients below and above 
65 years respectively, while Levy reported mortality rates of 20% and 45% 
in patients below and above 50 years.  Edelman observed mortality of 65% 
in patients above 65 years and 20% in those below 40 years. 
6. Fistula Output: 
Edmunds, Sitges –serra and Levy observed mortality rates of 54%, 
32% and 50% for high output fistulas and 16%, 6% and 26% for low output 
fistulas respectively. 
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7. Nutritional Status: 
Chapman observed a mortality rate of 12% and spontaneous closure in 
89% of patients with ECF who received more than 3000 kcal/24 hrs.  But in 
patients who received less than 1000 kcal/24 hrs, the corresponding values 
were 55% and 37%.  Coutsoffides reported mortality rates of 32% and 4% in 
the malnourished and well-nourished respectively. 
Serum visceral protein levels can be used to predict the outcome in 
ECF.  Fazio reported mortality rates of 0% and 42% in patients with serum 
albumin above 3.5 gm/dl and below 2.5 gm/dl respectively.  Kuvshinoff et al 
reported that serum transferrin levels of > 200 mg/dl were predictive of 
spontaneous closure. 
8. Duration of fistula: 
Acute ECF are more likely to close spontaneously than chronic ones 
but the mortality is higher for acute than chronic fistulas.  Edelman reported 
a mortality of 40%, if the fistula appeared within five days and only 23% if 
it appeared more than 15 days after surgery. 
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Various authors have used a combination of factors to identify classes 
with different risks of mortality.  Sitges – serra classified fistulas into four 
groups with mortality ranging from 60% in group 2 to 0% in group 3 and 
spontaneous closure of 7% in group 2 and more than 90% in group 1a and 
group 3.  When this classification was used in treating patient prospectively, 
mortality rates reduced and spontaneous closure increased. 
Fujita et al proposed four degrees of ECF depending on presence of 
abscess/peritonitis with mortality ranging from 0% to 65% in these classes 
Levy classified fistulas into four classes based on 12 risk factors with 
mortality of 0%, when no risk factor was present and 86% when two or more 
risk factors present.  Altomare el at developed a fistula prognostic score 
using four factors:  Sepsis, serum albumin, high output and locally 
unfavorable conditions.  Later they proposed a prognostic index based on 
logistic regression analysis using two risk factors – Apache II score and 
serum albumin levels.  Most of the prognostic factors identified can be 
included in the Apache II score or may have relevance in determining the 
Apache II score, so that this variable alone can indicate the relative 
importance of these risk factors fairly accurately.  They used this to evaluate 
prospectively patients with ECF and obtained an accuracy of 94%, positive 
predictive value of 92% and negative predicted value of 100%. 
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MATERIALS AND METHODS 
This was a prospective and retrospective study conducted at the 
Government Royapettah Hospital, Kilpauk Medical College, Chennai.  The 
period of study was from June 2005 to September 2007.  All patients with 
ECF were enrolled in this study.  Patients with biliary, pancreatic, and anal 
fistulas were excluded. 
Initial management for all patients was conservative, with restoration 
of fluid and electrolyte balance being given the first priority.  All patients 
were initially started on parenteral nutrition using 10% dextrose, Astymine, 
and human albumin.  Later some were switched over to enteral feeds 
depending on the clinical situation. 
Patients with clinical features of sepsis were subjected to an 
ultrasound examination and treated with transperitoneal drainage.  
Emergency surgical intervention was undertaken only in patients who had an 
intra-abdominal abscess.  Diversion procedures were undertaken in some 
patients at this time.  Elective surgical closure was done if the fistula failed 
to close spontaneously after four weeks of conservative management. 
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A Proforma was made and all cases of enterocutaneous fistulas were 
followed up from the day of recognition of fistula and till the date of 
discharge. Details regarding types of surgery performed, category of the 
fistula, and origin of fistula were collected.  Management policies for each 
patient are individualized and details of management were taken down. 
Analysis of morbidity and mortality were taken into the study. 
A thorough retrospective analysis of all cases was made to chalk out 
the principles for prevention of enterocutaneous fistulas. 
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OBSERVATIONS 
A total of 31 patients were studied.  There were 20 males and 11 
females in this group.  The age of the patients ranged from 10-70 years with 
mean age of 39 years.  Majority of the fistulas were observed in patients in 
the age group of 31 to 60 years – 16 patients. 
Out of 31 fistulas, 29 were postoperative.  One was due to trauma and 
other a case of strangulated inguinal hernia.  Among the former group, 70% 
developed a fistula following emergency surgery.  The mean interval 
between the initial surgery and the appearance of fistula was 9 days. 
Ileal fistulas were the most common accounting for 48% of the 
patients. 
ORIGIN NO. OF PATIENTS 
STOMACH 3 (9.67%) 
DUODENUM 4 (12.90%) 
JEJUNUM 3 (9.67%) 
ILEUM 15 (48.38%) 
COLON/APPENDIX 6 (19.35%) 
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Among the surgeries responsible for ECF, perforation closure 
accounted for the maximum in 11 patients. 
OPERATIONS NO. OF PATIENTS 
Perforation Closure 11 
Subtotal Gastrectomy 3 
Adhesiolysis 2 
Intestinal Resection & Anastomosis 9 
Emergency appendicectomy 1 
Others 5 
 
Out of 31 patients, 15 had high output and 16 had low output fistulas. 
Number 
of Patients Location 
High output Low output 
Stomach 2 1 
Duodenum 4 - 
Jejunum 3 - 
Ileum 6 9 
Colon - 6 
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Among the prognostic/severity factors studied, sepsis was occurring 
in 10 patients of whom 7 had an intra-abdominal abscess one had urinary 
tract infection and 2 had catheter related sepsis.  Malnutrition was seen in 11 
patients, hypoalbuminemia in 5 patients.  Thirteen patients had a large 
abdominal wall defect, 6 had cardiorespiratory problem and 11 were above 
51 years. 
Of the 31 patients, four had no severity factors, 14 had one factor, and 
the remaining had four or more severity factors. 
RISK FACTORS AND OUTCOME 
Risk factors No. of 
Patients 
Spontaneous 
closure 
Operative 
closure 
Dead
Age >51 years 11 4 3 4 
Sepsis 10 2 6 2 
Malnutrition 11 3 5 3 
Large abdominal wall 
defect 
13 3 6 4 
High output 15 4 7 4 
Sr. Albumin < 3 gm% 5 - - 5 
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Complications included skin excoriation around the fistula in 7 
patients, cardiopulmonary complication in 6, bedsores in 3 patients.  The 
commonest electrolyte imbalance was hyponatremia occurring in 8 patients. 
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RESULTS 
Fistulas closed in 11 patients spontaneously.  Operative closure was 
needed in 15 patients.  Death occurred in 5 patients with a mortality rate of 
16.12%. 
FINAL OUTCOME 
Outcome No. of Patients 
Closed by surgical intervention 15 
Spontaneous closure 11 
Death 5 
 
In two patients, death was due to uncontrolled sepsis, in two patients 
aspiration causing death.  Thromboembolism caused death in one patient.  
Out of five deaths, four were above 51 years of age.  All five patients died 
during the initial conservative treatment period. 
Surgical closure was achieved by resection and anastomosis in a 
majority of patients. 
  54
 
 
 
 
  55
ORGAN OF ORIGIN AND OUTCOME 
Organs Spontaneous 
Closure 
Operative 
Closure 
Death Total 
Patients 
Stomach 1 - 2 3 
Duodenum 3 - 1 4 
Jejunum 1 2 - 3 
Ileum 3 11 1 15 
Appendix/Colon 3 2 1 6 
Total 11 15 5 31 
 
Patients with single or no risk factors, had no mortality whereas 
mortality steadily rose as risk factors accumulated. 
The mean duration of the fistula closure was achieved in 28 days in 
case of spontaneous closure. 
Among the risk factors analyzed, the presence of a large abdominal 
wall defect and high output fistulas were significantly associated with failure 
of the fistula to close spontaneously 
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Hypoalbuminemia, malnutrition and sepsis were associated with high 
mortality. 
Serum albumin levels measured at the beginning of treatment showed 
no significant difference between patients who had spontaneous closure and 
those who did not, but there was a significant difference in serum albumin 
levels at the beginning of treatment between survivors and non-survivors. 
EFFECTS OF TPN 
Effects of TPN No. of Cases 
Spontaneous Closure 8 
Improvement in general Condition 6 
Catheter Sepsis 2 
 
In evaluating the effects of TPN: 
¾ It increases the spontaneous closure rate of fistulas. 
¾ It has contributed to decreased mortality in patients with fistula. 
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¾ Even if spontaneous closure has not been achieved because of 
complex fistula anatomy, the patients were in a better condition to be 
taken up for definite surgery. 
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DISCUSSION 
The outcome of treatment of enterocutaneous fistulas vary widely 
from hospital to hospital, mortality rates quoted in literature varies from 
6.25% to 60%.  Spontaneous closure occurs in 30 to 70%.  This is because 
of the heterogeneous nature of this condition.  This study revealed a 
mortality rate of 16.12% and spontaneous closure rate of 35.48% which is 
similar to other studies in literature.  Ileal fistulas in this study closed 
spontaneously in 20% of the cases, which is also similar to other series 
where the rates are less than 40%, despite it being an anatomically 
favourable location. 
Among the factors analyzed, the only factor that was predictive of 
spontaneous closure was the size of the abdominal wall defect.  It was found 
that malnutrition, hypoalbuminemia and large abdominal wall defect were 
all predictive of mortality.  Altomare et al showed that sepsis, serum 
albumin and high output were significantly related to the risk of death in 
ECF, which is similar to our study. 
In this study, spontaneous closure occurred within 35 days of 
appearance of the fistula in all cases, with the mean of 28 days, which is 
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similar to other studies.  Operative closure was undertaken between 4-6 
weeks except in one case, where it was done in the first week along with 
emergency drainage of an intra-abdominal abscess. 
In the 11 patients who had spontaneous closure, only two had sepsis 
(controlled) three had malnutrition (corrected) and three had large abdominal 
wall defect.  None of them had hypoalbuminemia.  Mortality in this series 
was due to a combination of risk factors, with the rate increasing as these 
factors accumulated. 
Among the 15 cases that needed operative closure, 6 had distal 
obstruction, 6 had sepsis, 6 had large abdominal wall defect. 
Although serum albumin levels at the appearance of the fistula did not 
predict spontaneous closure, it was predictive of mortality.  The albumin 
levels after three weeks of treatment however were predictive of both 
spontaneous closure and mortality.  This shows that improving the 
nutritional status of the patient, as evidenced by the increase in serum 
albumin levels, after three weeks of treatment increases the chances of 
spontaneous closure.  Similarly failure to correct malnutrition as evidenced 
by decreased serum albumin levels after three weeks increases the mortality. 
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Altomare et al reported a statistically significant difference in albumin levels 
between survivors and nonsurvivors. 
In this study, it is also clear that TPN increases the spontaneous 
closure rate and decreases the mortality. 
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PRINCIPLES OF PREVENTION 
Since operations account for most of the enterocutaneous fistulas, if 
we adopt certain principles, we can effectively prevent this humiliating and 
demoralizing phenomenon. 
Preoperative measures: 
• Effective bowel sterilization 
• Good nutritional support 
• Avoid radiotherapy 
Intra operative measures: 
• Sound Technical principle 
• Anastomosis in healthy bowel with adequate blood supply. 
• Anastomosis without tension 
• Proper hemostasis 
• Anastomosis covered with omentum 
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• Extra care being taken in patients with malignant lesion. 
Post operative measures: 
• Proper antibiotic therapy. 
• Early management of focal sepsis 
• Good Nutrition support. 
If attention is paid to all the several aspects of these preventive 
measures, gastrointestinal fistula following surgery can no longer be a 
nightmare to the surgeon. 
  66
CONCLUSION 
All cases of enterocutaneous fistulas should be regarded as a 
challenge by the surgeon. 
It may be concluded from this study: 
¾ Operations account for the majority of enterocutaneous fistulas 
¾ Surgical interventions for neoplastic lesions commonly result in 
enterocutaneous fistulas. 
¾ Anatomical origin of fistula, bowel wall defect, associated adverse 
factors like sepsis, malnutrition, serum albumin level, and abdominal 
wall defect influence the spontaneous closure. 
¾ Total parental nutrition increases the rate of spontaneous closure of 
fistulas and also decreases the mortality rate. 
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Definitive surgery should be carried out in the following patients: 
¾ Spontaneous closure not occurred even after four to six weeks of 
conservative therapy 
¾ Patients having complex fistula anatomy 
¾ Patients having distal bowel obstruction 
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PROFORMA 
Name:        Age/Sex: 
         I.P. No: 
D.O.A:        D.O.S.: 
D.O.D: 
History: 
Clinical features: 
Investigations: 
Diagnosis: 
Procedure Done: 
Post op. Period: 
Recognition of Fistula: 
Day:    Output:    Other symptoms: 
Malnutrition: 
Abdominal wall defect: 
Phase I Stabilization: 
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Phase II Investigations: 
 Serum Albumin 
 Fistulogram 
 USG. Abdomen 
 Others: 
Decision:      Conservative/Surgical: 
Outcome: 
Study Details 
  Surgery Performed: 
  Origin of fistula: 
  Output: 
  Management: 
  Outcome: 
Duration of Hospital Stay: 
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MALE FEMALE RATIO
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35.49%
Male
Female
 
  74
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FISTULA ORIGIN AND OUTPUT
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INCIDENCE OF EC FISTULA IN TYPE OF SURGERY
Emergency
70%
Elective
30%
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OUTCOME
48.38%
35.48%
16.14%
Surgical Closure
Spontaneous Closure
Death
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S.No. Name Age Sex IPNo. Clinical 
Diagnosis 
Initial Surgery Fistula 
Origin 
Output Ab 
wall 
defect 
Sepsis Diagnosis S.Albu 
min 
Out 
come 
Closure Definitive 
Surgery 
Cause of 
death 
1 Panjali 30 F 860311 Hollow 
viscus perf.  
Ileal perf. 
closure 
Ileum Low - Present Enteric 
fever 
 Closed Spontane
ous 
-  
2 Shaheena 55 F 871312 Intestinal 
obstruction 
Gangrenous 
bowel resection 
and anastomosis 
Colon Low -  Ca 
ascending 
colon 
 Closed Spontane
ous 
-  
3 Jesudas 49 M 861031 Intestinal 
obstruction 
Adhesiolysis Ileum High Present -   Closed Surgical Resection 
and 
anastomosis 
 
4 Kamala 55 F 861059 Sigmoid 
growth 
Resection and 
anastomosis 
Colon Low -  Ca sigmoid 
colon 
 Closed  Surgical Resection 
and 
anastomosis 
 
5 Patchammal 65 F 860032 Ca rectum Anterior 
resection 
Ileum High Present - Ca rectum  Recovery Surgical Resection 
and 
anastomosis 
 
6 Jagadeeswari 42 F 859989 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum High Present Present Enteric 
fever 
 Closed Surgical Resection 
and 
anastomosis 
 
7 Muthaiah 61 M 870012 Ca stomach Subtotal 
gastrectomy 
Stomach Low - - Ca stomach  Closed Spontane
ous 
  
8 Vetrivel 53 M 863221 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum Low - - Enteric 
fever 
 Closed Surgical Resection 
and 
anastomosis 
 
9 Karim 42 M 861111 Blunt injury 
abdomen 
Jejunal rent 
closure 
Jejunum High - - Trauma  Closed Surgical Simple 
closure 
 
10 Ramesh 9 M 860132 Appendicitis Appendicectomy Appendicul
ar stum 
Low - - Appendicitis  Closed Spontane
ous 
  
11 Devendran 33 M 866322 RTA Primary wound 
closure 
Sigmoid Low - - Trauma  Recovery Surgical Diversion 
colostomy 
 
12 Srikumar 21 M 871124 Hollow 
viscus perf. 
DU perf. closure Duodenum High Present - DU perf.  Closed Spontane
ous 
  
13 Mannu 59 M 869389 Ca stomach Sub total 
gastrectomy 
Stomach High Present - Ca stomach < 3 gm 
% 
Died   Aspiration 
14 Srinath 68 M 867321 Cholelithiasis Cholecystectomy 
/ CBD 
exploration 
Duodenum High Present -  < 3 gm 
% 
Died   Thromboe
mbolism 
15 Gugan 47 M 871121 Chronic 
pancreatitis 
Pancreatico 
jejunostomy 
Jejunum High Present Present Chronic 
pancreatitis 
 Recovery Surgical Resection 
and 
anastomosis 
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16 Srinivas 70 M 873519 Intestinal 
obstruction 
Resection and 
anastomosis 
colon Low - - Ca 
ascending 
colon 
 Closed Spontane
ous 
  
17 Gomathi 37 F 863245 Intestinal 
obstruction 
Adhesiolysis Jejunum High - -   Closed Spontane
ous 
  
18 Sabapathy 42 M 877112 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum High Present    Closed Surgical Resection 
and 
anastomosis 
 
19 Malar 25 F 871142 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum Low - Present Enteric 
fever 
 Recovery Surgical Resection 
and 
anastomosis 
 
20 Suresh 21 M 873241 Hollow 
viscus perf. 
DU perf. closure Duodenum High Present - DU perf.  Closed Spontane
ous 
  
21 Baskar 19 M 874215 Intestinal 
obstruction 
Gangrene bowel 
resection and 
anastomosis 
Ileum Low - -   Recovery Surgical Resection 
and 
anastomosis 
 
22 Raju 20 M 875632 Multiple 
splenic 
abscess 
Splenectomy Ileum Low - - Chron’s 
disease 
 Recovery Surgical Resection 
and 
anastomosis 
 
23 Velumani 60 M 863215 Abscess 
inguinal 
region 
I & D Ileum Low - - Obstructed 
Inguinal 
hernia 
 Closed Spontane
ous 
  
24 Ashwin 40 M 871142 Hollow 
viscus perf. 
DU perf. closure Duodenum High Present - DU perf.  Closed Spontane
ous 
  
25 Pankajam 26 F 880032 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum High Present Present TB  Recovery Surgical Diversion 
Ileostomy 
 
26 Durai 13 M 873214 Intestinal 
obstruction 
Resection and 
anastomosis 
Ileum Low - Present   Recovery Surgical Ileostomy  
27 Sangeetha 21 F 880351 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum High Present Present Enteric 
fever 
< 3 gm % Died   Sepsis 
28 Ramanathan 58 M 881321 Ca Stomach Sub total 
gastrectomy 
Stomach High Present - Ca stomach < 3 gm % Died   Aspiration 
29 Gowri 36 F 884321 Appendicitis Meckel’s 
diverticulectomy 
Ileum Low - Present   Closed Spontane
ous 
  
30 Balaraman 55 M 885536 Ca colon Resection and 
anastomosis 
Colon Low - Present Ca sigmoid 
colon 
< 3 gm % Died   Sepsis 
31 Malarvizhi 27 F 881573 Hollow 
viscus perf. 
Ileal perf. 
closure 
Ileum Low - Present Enteric 
fever 
 Recovery Surgical Resection 
and 
Anastomosis 
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ABBREVIATIONS 
 
 
Ca  - Carcinoma 
CBD  - Common bile duct 
CVP  - Central venous pressure 
DU  - Duodenal ulcer 
EC  - Enterocutaneous 
ECF  - Enterocutaneous fistula 
IBD  - Inflammatory bowel disease 
NG  - Nasogastric 
Perf  - Perforation 
Post op - Post operative 
Pre op - Pre operative 
TPN  - Total parenteral nutrition 
 
 
 
